AltaVoice is a Silicon Valley-based company that is dedicated to revolutionizing the way patient data is utilized to drive innovative methods for treating diseases. The company's mission is encapsulated in its slogan, "Delivering Speedy, Cost-effective Patient Insights to Optimize Treatment for Diseases." AltaVoice focuses on building and managing Patient Insights Networks (PINs), which serve as highly efficient platforms for aggregating, organizing, and disseminating health data reported by patients and clinicians.
One of the key strengths of AltaVoice's approach is its ability to deliver patient insights more rapidly and in a more cost-effective manner compared to traditional registries and Contract Research Organizations (CROs). The company places a strong emphasis on continuous patient engagement and collaborative efforts, facilitating connections between drug developers, advocacy groups, and academic researchers to drive advancements in disease treatment.
Established in 2004, AltaVoice has actively engaged in initiatives for over 400 diseases, partnering with more than 100 advocacy organizations, as well as institutions such as the NIH, PCORI, and various biotech and pharmaceutical firms. The company's impactful work garnered recognition in 2016 when it was honored with an invitation by Vice President Joe Biden to participate in the Cancer Moonshot events at the Whitehouse.
AltaVoice's ambitious strategy not only promotes the swift and cost-effective delivery of patient insights for medical progress, but also facilitates global synchronization of data collection efforts by advocacy organizations while preserving their unique brand identities. With its unwavering commitment to breaking down data barriers in medicine, AltaVoice is poised to make significant contributions to the biotechnology and healthcare industries.
